All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted earlier in 2024, this drug is unlikely to be needed for those heart patients …
“The Oncologist Outside the Exam Room” published on Dec 2024 by National Comprehensive Cancer Network.
A study aim to expand treatment options for patients with IDH1-mutant MDS, a challenging subset of patients characterized by poor prognosis.
AbstractCardiac masses encompass a diverse range of benign and malignant tumors as well as pseudotumors. Accurate histologic identification is essential for guiding appropriate treatment, yet…
A study’s efficacy and safety findings show promise for lovo-cel as a one-time intervention for SCD with history of stroke.
For patients with single-ventricle congenital heart disease, staged surgical palliation to total cavopulmonary anastomosis, or Fontan palliation, offers long-term survival but results in complex and…
A study analyzed the fecal microbiome of patients with IgA nephropathy (IgAN), focusing on their immune response to microbiota.
Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital, Milan, Italy Herz- und Thorakale Gefässchirurgie FMH, Zürich, Switzerland Gard Consulting, Borgomasino, Italy Vita-Salute San Raffaele University,…
Many of my patients are trying to lower their cholesterol levels and many want to avoid prescription medications. The Portfolio Diet is not well known…
Lipoprotein(a) is an inherited cholesterol particle effected 20-25% of all persons on the planet and it can harm arteries and heart valves throughout life. Stan
Lipoprotein(a) or Lp(a) is a “sticky cholesterol” particle under genetic control that is different than the lipids measured on a routine clinic visit. It must…
